New drug duo tested as last hope for tough cancers

NCT ID NCT03797326

Summary

This study tested the safety and effectiveness of combining two drugs, pembrolizumab and lenvatinib, in people with advanced solid tumors that had stopped responding to standard treatments. It involved 611 participants with cancers like triple-negative breast, ovarian, gastric, colorectal, and pancreatic cancer. The goal was to see if this combination could shrink tumors and control the disease for people with limited options.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Alfred Health ( Site 0902)

    Melbourne, Victoria, 3004, Australia

  • Arkhangelsk Clinical Oncological Dispensary ( Site 1600)

    Arkhangelsk, Arkhangelskaya oblast, 163045, Russia

  • Asan Medical Center ( Site 1002)

    Songpagu, Seoul, 05505, South Korea

  • BC Cancer - Abbotsford ( Site 0200)

    Abbotsford, British Columbia, V2S 0C2, Canada

  • CEMIC ( Site 2104)

    Buenos Aires, C1431FWO, Argentina

  • CHU de Quebec Universite de Laval ( Site 0206)

    Québec, Quebec, G1R 2J6, Canada

  • Cambridge University Hospitals NHS Trust ( Site 0803)

    Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom

  • CancerCare Manitoba ( Site 0201)

    Winnipeg, Manitoba, R3E 0V9, Canada

  • Cedars Sinai Medical Center ( Site 0003)

    Los Angeles, California, 90048, United States

  • Centre Antoine Lacassagne ( Site 0404)

    Nice, Alpes-Maritimes, 06189, France

  • Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0210)

    Montreal, Quebec, H2X 3E4, Canada

  • Centre Leon Berard ( Site 0405)

    Lyon, Auvergne, 69373, France

  • Centre Oscar Lambret ( Site 0401)

    Lille, Nord, 59000, France

  • Centro Investigación del Cáncer James Lind ( Site 1203)

    Temuco, Región de la Araucanía, 4780000, Chile

  • Chaim Sheba Medical Center ( Site 0600)

    Ramat Gan, 5262000, Israel

  • Christie NHS Foundation Trust ( Site 0805)

    Manchester, M20 4BX, United Kingdom

  • Chulalongkorn University ( Site 5001)

    Bangkok, Bangkok, 10330, Thailand

  • City Clinical Oncology Center ( Site 1608)

    Saint Petersburg, Sankt-Peterburg, 198255, Russia

  • City of Hope ( Site 0002)

    Duarte, California, 91010, United States

  • Clinica Universitaria de Navarra ( Site 0704)

    Madrid, 28027, Spain

  • Fondazione Policlinico Universitario A. Gemelli ( Site 1403)

    Roma, 00168, Italy

  • Fundacion Arturo Lopez Perez ( Site 1201)

    Santiago, Region M. de Santiago, 7500921, Chile

  • Fundacion Colombiana de Cancerologia Clinica Vida ( Site 1105)

    Medellín, Antioquia, 050030, Colombia

  • Fundacion Favaloro para la Docencia e Investigacion Medica ( Site 2106)

    Ciudad Autonoma de Buenos Aires, Buenos Aires, C1078AAI, Argentina

  • Fundacion Valle del Lili ( Site 1101)

    Cali, Valle del Cauca Department, 760032, Colombia

  • Guy's Hospital ( Site 0806)

    London, London, City of, SE1 9RT, United Kingdom

  • HELIOS Dr. Horst Schmidt Kliniken Wiesbaden ( Site 0301)

    Wiesbaden, Hesse, 65199, Germany

  • Hadassah Ein Kerem Medical Center ( Site 0604)

    Jerusalem, 9112001, Israel

  • Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0208)

    Hamilton, Ontario, L8V 4X2, Canada

  • Hopitaux Universitaires de Geneve HUG ( Site 1701)

    Geneva, 1211, Switzerland

  • Hospital Aleman ( Site 2100)

    Buenos Aires, Buenos Aires F.D., 1118, Argentina

  • Hospital Britanico de Buenos Aires ( Site 2109)

    Ciudad de Buenos Aires, Buenos Aires F.D., C1280AEB, Argentina

  • Hospital Clinic i Provincial ( Site 0703)

    Barcelona, 08036, Spain

  • Hospital Clinico Universidad de Chile ( Site 1200)

    Santiago, Region M. de Santiago, 8380456, Chile

  • Hospital Ramon y Cajal ( Site 0702)

    Madrid, 28034, Spain

  • Hospital Universitario Gregorio Maranon ( Site 0701)

    Madrid, 28009, Spain

  • IDIM Instituto de Diagnostico e Investigaciones Metabolicas ( Site 2101)

    Caba, C1012AAR, Argentina

  • Inselspital Universitaetsspital Bern ( Site 1705)

    Bern, Canton of Bern, 3010, Switzerland

  • Institut Claudius Regaud IUCT Oncopole ( Site 0403)

    Toulouse, Haute-Garonne, 31059, France

  • Institut Gustave Roussy ( Site 0400)

    Villejuif, Val-de-Marne, 94800, France

  • Institut de Cancerologie de l Ouest Centre Rene Gauducheau ( Site 0402)

    Saint-Herblain, Val-de-Marne, 44805, France

  • Instituto Nacional de Cancerologia E.S.E ( Site 1102)

    Bogotá, Bogota D.C., 110321, Colombia

  • Instituto de Oncologia de Rosario ( Site 2105)

    Rosario, Santa Fe Province, S2000KZE, Argentina

  • Istituto Clinico Humanitas Research Hospital ( Site 1402)

    Rozzano, Milano, Italy

  • Istituto Nazionale Tumori Fondazione Pascale ( Site 1400)

    Napoli, 80131, Italy

  • Kantonsspital Graubuenden ( Site 1704)

    Chur, Kanton Graubünden, 7000, Switzerland

  • Kantonsspital St. Gallen ( Site 1702)

    Sankt Gallen, Canton of St. Gallen, 9007, Switzerland

  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0023)

    New York, New York, 10016, United States

  • Lehigh Valley Hospital- Cedar Crest ( Site 0047)

    Allentown, Pennsylvania, 18103, United States

  • Leicester Royal Infirmary. Univ. Hosp. of Leicester NHS Trust ( Site 0804)

    Leicester, Leicestershire, LE1 5WW, United Kingdom

  • Leningrad Regional Oncology Center ( Site 1609)

    Saint Petersburg, Sankt-Peterburg, 188663, Russia

  • Mary Crowley Cancer Research Centers - Medical City Hospital ( Site 0049)

    Dallas, Texas, 75230, United States

  • National Cheng Kung University Hospital ( Site 3003)

    Tainan, 704, Taiwan

  • National Taiwan University Hospital ( Site 3000)

    Taipei, 10002, Taiwan

  • Oncologos del Occidente S.A. ( Site 1106)

    Pereira, Risaralda Department, 660001, Colombia

  • Ospedale Regionale di Bellinzona e Valli ( Site 1703)

    Bellinzona, Canton Ticino, 6500, Switzerland

  • Policlinico Le Scotte - A.O. Senese ( Site 1401)

    Siena, Tuscany, 53100, Italy

  • Pontificia Universidad Catolica de Chile ( Site 1202)

    Santiago, Region M. de Santiago, 8330024, Chile

  • Princess Margaret Cancer Centre ( Site 0202)

    Toronto, Ontario, M5G 2M9, Canada

  • Ramathibodi Hospital. ( Site 5002)

    Bangkok, Bangkok, 10400, Thailand

  • Rambam Medical Center ( Site 0602)

    Haifa, 3109601, Israel

  • Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1603)

    Kazan', Tatarstan, Respublika, 420029, Russia

  • Robert Bosch GmbH ( Site 0307)

    Stuttgart, Baden-Wurttemberg, 70376, Germany

  • Royal Brisbane and Women s Hospital ( Site 0901)

    Herston, Queensland, 4029, Australia

  • Royal Marsden Hospital (Sutton) ( Site 0800)

    London, Surrey, SM3 5PT, United Kingdom

  • Russian Oncological Research Center n.a. N.N. Blokhin ( Site 1604)

    Moscow, Moscow, 115478, Russia

  • Rutgers Cancer Institute of New Jersey ( Site 0009)

    New Brunswick, New Jersey, 08901, United States

  • SRH Wald-Klinikum Gera GmbH ( Site 0309)

    Gera, Thuringia, 07548, Germany

  • Sanford Cancer Center ( Site 0058)

    Sioux Falls, South Dakota, 57104, United States

  • Sanford Fargo Medical Center ( Site 0059)

    Fargo, North Dakota, 58102, United States

  • Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 1610)

    Saint Petersburg, Sankt-Peterburg, 197758, Russia

  • Seoul National University Hospital ( Site 1000)

    Seoul, 03080, South Korea

  • Severance Hospital Yonsei University Health System ( Site 1001)

    Seoul, 03722, South Korea

  • Sir Charles Gairdner Hospital ( Site 0903)

    Nedlands, Western Australia, 6009, Australia

  • Siriraj Hospital ( Site 5003)

    Bangkok, Bangkok, 10700, Thailand

  • Soroka Medical Center ( Site 0601)

    Beersheba, 8457108, Israel

  • Sourasky Medical Center ( Site 0603)

    Tel Aviv, 6423906, Israel

  • Sunnybrook Research Institute ( Site 0207)

    Toronto, Ontario, M4N 3M5, Canada

  • Swedish Medical Center ( Site 0021)

    Seattle, Washington, 98104, United States

  • Universitaetsklinikum Frankfurt ( Site 0306)

    Frankfurt am Main, Hesse, 60528, Germany

  • Universitaetsklinikum Jena ( Site 0302)

    Jena, Thuringia, 07740, Germany

  • Universitaetsklinikum Regensburg ( Site 0304)

    Regensburg, Bavaria, 93053, Germany

  • Universitaetsspital Zurich ( Site 1700)

    Zurich, 8091, Switzerland

  • University of California Davis Comprehensive Cancer Center ( Site 0005)

    Sacramento, California, 95817, United States

  • University of Colorado, Anschutz Cancer Pavilion ( Site 0007)

    Aurora, Colorado, 80045, United States

  • University of Florida-Health Cancer Center-Orlando ( Site 0015)

    Orlando, Florida, 32806, United States

  • University of Wisconsin Carbone Cancer Center ( Site 0017)

    Madison, Wisconsin, 53792-0001, United States

  • West Cancer Center - East Campus ( Site 0018)

    Germantown, Tennessee, 38138, United States

Conditions

Explore the condition pages connected to this study.